Palmer Knight Company’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.57M Sell
22,163
-512
-2% -$190K 3.3% 11
2026
Q1
$6.64M Buy
22,675
+2,243
+11% +$737K 3.24% 21
2025
Q4
$7.16M Buy
20,432
+10,162
+99% +$3.43M 3.76% 15
2025
Q3
$3.32M Sell
10,270
-253
-2% -$78.7K 1.57% 28
2025
Q2
$4.09M Sell
10,523
-20
-0.2% -$8.04K 1.74% 30
2025
Q1
$4.59M Sell
10,543
-174
-2% -$69.8K 2.23% 26
2024
Q4
$3.95M Buy
10,717
+213
+2% +$89.1K 1.77% 28
2024
Q3
$5.46M Buy
10,504
+49
+0.5% +$26.2K 2.4% 28
2024
Q2
$5.67M Buy
10,455
+88
+0.8% +$46.5K 2.71% 23
2024
Q1
$5.38M Buy
+10,367
New +$5.16M 2.62% 25

Other funds holding ELV

Palmer Knight Company's ELV Position: Q2 2026 in Review

Palmer Knight Company reduced its Elevance Health (ELV) stake by 2.3% in Q2 2026, selling an estimated $190K and leaving 22,163 shares worth $8.57M. The position accounts for 3.3% of the portfolio, ranked #11.

Palmer Knight Company first reported a position in ELV in Q1 2024 and has held it in 10 quarters since. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Palmer Knight Company held 22,163 shares of Elevance Health worth $8.57M as of Q2 2026.
  • Palmer Knight Company sold 512 Elevance Health shares in Q2 2026, an estimated $190K.
  • Elevance Health made up 3.3% of Palmer Knight Company's portfolio in Q2 2026, its #11 holding.
  • Palmer Knight Company first reported a position in Elevance Health in Q1 2024 and has held it in 10 quarters since.
  • 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Palmer Knight Company's 13F filing for Q2 2026, filed 10 Aug 2026.